Literature DB >> 30922053

Evaluation of in vitro effect of selected contact lens solutions conjugated with nanoparticles in terms of preventive approach to public health risk generated by Acanthamoeba strains.

Marcin Padzik1, Edyta B Hendiger2, Agnieszka Żochowska3, Jarosław Szczepaniak4, Wanda Baltaza5, Anna Pietruczuk-Padzik6, Gabriela Olędzka7, Lidia Chomicz8.   

Abstract

INTRODUCTION: Various<i> Acanthamoeba</i> species are free-living organisms widely distributed in the human environment. Amphizoic amoebae as facultative parasites may cause vision-threatening eye disease - <i>Acanthamoeba</i> keratitis, mostly among contact lens wearers. As the number of cases is increasing, and applied therapy often unsuccessful, proper hygienic measures and effective contact lenses disinfection are crucial for the prevention of this disease. Available contact lens solutions are not fully effective against amphizoic amoebae; there is a need to enhance their disinfecting activity to prevent amoebic infections. The use of developing nanotechnology methods already applied with success in the prevention, diagnostic and therapy of other infectious diseases might be helpful regarding amoebic keratitis. This study assesses the in vitro effect of selected contact lens solutions conjugated with nanoparticles against <i>Acanthamoeba</i> trophozoites.
MATERIAL AND METHODS: Three selected contact lens solutions conjugated with silver and gold nanoparticles in concentration of 0.25-2.5 ppm were used in vitro against the axenically cultured ATCC 30010 type <i>Acanthamoeba</i> castellanii strain. The anti-amoebic efficacy was examined based on the oxido-reduction of AlamarBlue. The cytotoxicity tests based on the measurement of lactate dehydrogenase (LDH) activity were performed using a fibroblast HS-5 cell line.
RESULTS: Enhancement of the anti-amoebic activity of contact lens solutions conjugated with selected nanoparticles expressed in the dose dependent amoebic growth inhibition with a low cytotoxicity profile was observed.
CONCLUSIONS: Results of the study showed that conjugation of selected contact lens solutions with silver nanoparticles might be a promising approach to prevent <i>Acanthamoeba</i> keratitis among contact lens users.

Entities:  

Keywords:  Acanthamoeba keratitis; Acanthamoeba trophozoites; anti-amoebic in vitro effect; contact lens solutions; silver/gold nanoparticles

Mesh:

Substances:

Year:  2019        PMID: 30922053     DOI: 10.26444/aaem/105394

Source DB:  PubMed          Journal:  Ann Agric Environ Med        ISSN: 1232-1966            Impact factor:   1.447


  4 in total

1.  New Insights in Acanthamoeba.

Authors:  María Reyes-Batlle; Ines Sifaoui; Rubén L Rodríguez-Expósito; José E Piñero; Jacob Lorenzo-Morales
Journal:  Pathogens       Date:  2022-05-23

2.  Silver Nanoparticles as a Novel Potential Preventive Agent against Acanthamoeba Keratitis.

Authors:  Edyta B Hendiger; Marcin Padzik; Ines Sifaoui; María Reyes-Batlle; Atteneri López-Arencibia; Aitor Rizo-Liendo; Carlos J Bethencourt-Estrella; Desirée San Nicolás-Hernández; Olfa Chiboub; Rubén L Rodríguez-Expósito; Marta Grodzik; Anna Pietruczuk-Padzik; Karolina Stępień; Gabriela Olędzka; Lidia Chomicz; José E Piñero; Jacob Lorenzo-Morales
Journal:  Pathogens       Date:  2020-05-05

3.  Tannic acid-modified silver nanoparticles enhance the anti-Acanthamoeba activity of three multipurpose contact lens solutions without increasing their cytotoxicity.

Authors:  Edyta B Hendiger; Marcin Padzik; Agnieszka Żochowska; Wanda Baltaza; Gabriela Olędzka; Diana Zyskowska; Julita Bluszcz; Sylwia Jarzynka; Lidia Chomicz; Marta Grodzik; Jacek Hendiger; José E Piñero; Jarosław Grobelny; Katarzyna Ranoszek-Soliwoda; Jacob Lorenzo-Morales
Journal:  Parasit Vectors       Date:  2020-12-22       Impact factor: 3.876

4.  Silver Nanoparticles Conjugated with Contact Lens Solutions May Reduce the Risk of Acanthamoeba Keratitis.

Authors:  Edyta B Hendiger; Marcin Padzik; Inés Sifaoui; María Reyes-Batlle; Atteneri López-Arencibia; Diana Zyskowska; Marta Grodzik; Anna Pietruczuk-Padzik; Jacek Hendiger; Gabriela Olędzka; Lidia Chomicz; José E Piñero; Jacob Lorenzo-Morales
Journal:  Pathogens       Date:  2021-05-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.